Evidence map›Paper›PMID 21764986›Full record

ArticleAmerican journal of physiology. Lung cellular and molecular physiology2011

Rab38 targets to lamellar bodies and normalizes their sizes in lung alveolar type II epithelial cells.

Linghui Zhang, Kevin Yu, Kyle W Robert, Kristine M DeBolt, Nankang Hong, Jian-Qin Tao, Mitsunori Fukuda, Aron B Fisher, Shaohui Huang

Open access · greenAbstract read
In one paragraph

Article in American journal of physiology. Lung cellular and molecular physiology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
1.3field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 32 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Article
  6. Observational
  7. Review
  8. International journal of molecular sciences · 2018
    Review
  9. Gene-edited MLE-15 Cells as a Model for the Hermansky-Pudlak Syndromes.American journal of respiratory cell and molecular biology · 2018
    Article
  10. Exogenous gene transfer of RabRespiratory research · 2017
    Article
  11. Pulmonary Fibrosis in Hermansky-Pudlak Syndrome.Annals of the American Thoracic Society · 2016
    Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Review
  18. Review
  19. Rab38 modulates proteinuria in model of hypertension-associated renal disease.Journal of the American Society of Nephrology : JASN · 2013
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 3 countries.

Linghui ZhangInstitute for Environmental Medicine, University of Pennsylvania School of Medicine, Philadelphia, 19104-6068, USA.
Kevin Yu
Kyle W Robert
Kristine M DeBolt
Nankang Hong
Jian-Qin Tao
Mitsunori Fukuda
Aron B Fisher
Shaohui Huang
Institute for Environmental Management · USJuniata College · USTohoku University · JPUniversity of Pennsylvania · US

Funding

UPTAKE AND REUTILIZATION OF SURFACTANT COMPONENTSP01HL019737 · NHLBI · UNIVERSITY OF PENNSYLVANIA · PI FISHER, ARON B. · 1985 to 2013
$23.6M
TRAINING IN LUNG CELL AND MOLECULAR BIOLOGYT32HL007748 · NHLBI · UNIVERSITY OF PENNSYLVANIA · PI FISHER, ARON B. · 1994 to 2013
$3.5M
NHLBI NIH HHS P01 HL-019737-34NHLBI NIH HHS T32 HL-007748-17
6 · The paper itself

Abstract

Rab38 is a rat Hermansky-Pudlak syndrome gene that plays an important role in surfactant homeostasis in alveolar type II (ATII) pneumocytes. We examined Rab38 function in regulating lamellar body (LB) morphology in ATII cells. Quantitative electron microscopy revealed that LBs in ATII cells were ∼77% larger in Rab38-null fawn-hooded hypertension (FHH) than control Sprague-Dawley (SD) rats. Rab38 protein expression was restricted in lung epithelial cells but was not found in primary endothelial cells. In SD ATII cells, Rab38 protein level gradually declined during 5 days in culture. Importantly, endogenous Rab38 was present in LB fractions purified from SD rat lungs, and transiently expressed enhanced green fluorescent protein (EGFP)-tagged Rab38 labeled only the limiting membranes of a subpopulation (∼30%) of LBs in cultured ATII cells. This selective targeting was abolished by point mutations to EGFP-Rab38 and was not shared by Rab7 and Rab4b, which also function in the ATII cells. Using confocal microscopy, we established a method for quantitative evaluation of the enlarged LB phenotype temporally preserved in cultured FHH ATII cells. A direct causal relationship was established when the enlarged LB phenotype was reserved and then rescued by transiently reexpressed EGFP-Rab38 in cultured FHH ATII cells. This rescuing effect was associated with dynamic EGFP-Rab38 targeting to and on LB limiting membranes. We conclude that Rab38 plays an indispensible role in maintaining LB morphology and surfactant homeostasis in ATII pneumocytes.

Indexed as

rab GTP-Binding ProteinsAlveolar Epithelial CellsAnimalsBlotting, WesternCells, CulturedEpithelial CellsGreen Fluorescent ProteinsHermanski-Pudlak SyndromeLungMaleMicroscopy, ElectronOrganellesOrganelle SizePhenotypePlasmidsPoint Mutationenhanced green fluorescent proteinGreen Fluorescent ProteinsRab38 protein, ratrab7 GTP-Binding Proteinsrab7 GTP-binding proteins, ratrab GTP-Binding Proteins

Identifiers

PMID21764986
PMCPMC3191760
OpenAlexW2019357028

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.